First Time Loading...

Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.35 USD -4.08%
Updated: Jun 10, 2024

Vivos Therapeutics Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vivos Therapeutics Inc
Accrued Liabilities Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Vivos Therapeutics Inc
NASDAQ:VVOS
Accrued Liabilities
$2.8m
CAGR 3-Years
17%
CAGR 5-Years
35%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Accrued Liabilities
$1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
5%
Quest Diagnostics Inc
NYSE:DGX
Accrued Liabilities
$153m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Accrued Liabilities
$24.1B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
17%
Cigna Corp
NYSE:CI
Accrued Liabilities
$8.9B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Accrued Liabilities
$820.6m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
9%

See Also

What is Vivos Therapeutics Inc's Accrued Liabilities?
Accrued Liabilities
2.8m USD

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Accrued Liabilities amounts to 2.8m USD.

What is Vivos Therapeutics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
35%

Over the last year, the Accrued Liabilities growth was 21%. The average annual Accrued Liabilities growth rates for Vivos Therapeutics Inc have been 17% over the past three years , 35% over the past five years .